MENU

MPLT MapLight Therapeutics Inc. Forecast, Technical & Fundamental Analysis

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more

MPLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
MPLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MPLT is expected to report earnings to fall 7.58% to -122 cents per share on December 03

MapLight Therapeutics Inc. MPLT Stock Earnings Reports
Q3'26
Est.
$-1.22
Q2'26
Missed
by $0.33
Q1'26
Missed
by $0.42
The last earnings report on August 13 showed earnings per share of -132 cents, missing the estimate of -99 cents. With 183.35K shares outstanding, the current market capitalization sits at 458.50M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALV118.882.94
+2.54%
Autoliv
FRPH19.240.43
+2.29%
FRP Holdings
WTFCN25.68-0.01
-0.04%
Wintrust Financial Corp
ALG147.23-1.27
-0.86%
Alamo Group
TPCS5.22-0.15
-2.79%
TechPrecision Corp
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
800 Chesapeake Drive
Phone
+1 617 984-6300
Employees
133
Web
https://www.maplightrx.com
MapLight Therapeutics (MPLT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com